NCT07317570 The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders
| NCT ID | NCT07317570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Recep Tayyip Erdogan University |
| Condition | Temporomandibular Joint Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2025-12-20 |
| Primary Completion | 2026-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2025-12-20 with a primary completion date of 2026-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, single-blind controlled trial aims to investigate the effectiveness of Body Awareness Therapy (BAT) on pain, functional limitations, and psychosocial outcomes in individuals with temporomandibular joint disorders (TMD). TMD is characterized by orofacial pain, impaired jaw function, and increased psychosocial burden, yet current physiotherapy approaches may not fully address the biopsychosocial mechanisms underlying these symptoms. BAT is a structured mind-body physiotherapy intervention designed to improve postural awareness, interoceptive sensitivity, breathing regulation, and movement control. In this study, participants will be randomly assigned to either BAT or a standard physiotherapy control intervention for a defined treatment period. Primary outcomes will include pain intensity and jaw functional limitations, while secondary outcomes will assess body awareness, anxiety, stress, and quality of life. Evaluations will be conducted at baseline and post-intervention. The findings of this trial may provide evidence for integrating biopsychosocial and awareness-based physiotherapy into TMD rehabilitation.
Eligibility Criteria
Inclusion Criteria: Adults aged 18-65 years. Diagnosed with Temporomandibular Joint Disorders (TMD) according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Experiencing orofacial pain or jaw functional limitation for at least the past 3 months. Ability to understand and follow verbal instructions required for Body Awareness Therapy sessions. Willingness to participate in the study and to attend all assessment and intervention sessions. Providing written informed consent. Exclusion Criteria: History of jaw trauma, fracture, or surgery within the past 6 months. Presence of systemic rheumatologic or inflammatory disorders (e.g., rheumatoid arthritis, ankylosing spondylitis) that may affect TMJ function. Neurological or psychiatric conditions that could interfere with participation or outcome assessments (e.g., major psychiatric disorder, cognitive impairment). Severe dental or orthodontic conditions requiring immediate treatment (e.g., acute infection, ongoing orthodontic procedures). Use of occlusal splints, bite guards, or other TMJ-related interventions initiated within the past 3 months. Participation in any other physiotherapy or exercise program targeting the jaw, cervical spine, or posture during the study period. Pregnancy, due to potential changes in joint laxity and pain perception. Current use of medications affecting neuromuscular or pain responses, such as muscle relaxants, corticosteroids, or neuropathic pain medications (unless dose has been stable for 3 months). Any contraindication to performing light-to-moderate physical activity or awareness-based exercises. Inability to attend scheduled therapy sessions or complete study assessments.
Frequently Asked Questions
Who can join the NCT07317570 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Temporomandibular Joint Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07317570 currently recruiting?
Yes, NCT07317570 is actively recruiting participants. Visit ClinicalTrials.gov or contact Recep Tayyip Erdogan University to inquire about joining.
Where is the NCT07317570 trial being conducted?
This trial is being conducted at Rize, Turkey (Türkiye).
Who is sponsoring the NCT07317570 clinical trial?
NCT07317570 is sponsored by Recep Tayyip Erdogan University. The trial plans to enroll 52 participants.